Implantation or Injectable Dosage Form New Animal Drugs; Polysulfated Glycosaminoglycan
other · Food and Drug Administration · Rule · Published 2009-12-21 · Effective 2009-12-21 · 74 FR 67815
Document
Document number
E9-30222
Federal Register citation
74 FR 67815
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2009-12-21
Effective date
2009-12-21
HHS docket
Docket No. FDA-2009-N-0665
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The supplemental NADA provides for additional vial sizes for an injectable solution of polysulfated glycosaminoglycan.